Bifurcation and Stability of a Mathematical Model for Tumor Growth with Oncolytic Virotherapy

被引:0
|
作者
Chen, Hong-Bing [1 ,2 ]
机构
[1] Northwest Normal Univ, Sch Math & Stat, Lanzhou 730070, Gansu, Peoples R China
[2] Tianshui Normal Univ, Sch Math & Stat, Tianshui 741001, Gansu, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Oncolytic virotherapy; T-OV-taxis; global bifurcation; stability; REACTION-DIFFUSION MODEL; DYNAMICS; VIRUS; ADENOVIRUS; EFFICACY; THERAPY; CELLS;
D O I
10.1142/S0218127423501687
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
Replication-competent viruses have been used as an alternative therapeutic approach for cancer treatment. In this paper, a T-OV-taxis mathematical model for tumor growth with oncolytic virotherapy is established. First, the stability of u* is studied in the ODE system and in the reaction-diffusion system of the model. It is found that the stability of u* will not be changed by diffusion alone. Next, the T-OV-taxis rate chi is selected as a bifurcation factor, and a threshold value chi(0) (chi(0) < 0) is found, such that positive constant steady-state u* becomes unstable when chi < chi(0). Hence, the taxis-driven Turing instability occurs. Furthermore, the existence, stability, turning direction of steady-state bifurcation are discussed. And, the local steady-state bifurcation is extended to a global one, where the theory used is the Crandall-Rabinowitz bifurcation theorem. Finally, it is concluded that T-OV-taxis rate chi plays an important role in this mathematical model.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] Oncolytic virotherapy for tumours following a Gompertz growth law
    Jenner, Adrianne L.
    Kim, Peter S.
    Frascoli, Federico
    JOURNAL OF THEORETICAL BIOLOGY, 2019, 480 : 129 - 140
  • [42] Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma
    Morales-Molina, Alvaro
    Gambera, Stefano
    Leo, Angela
    Garcia-Castro, Javier
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
  • [43] Stability Analysis of Tumor treatment model using Virotherapy and Chemotherapy
    Srilatha, R.
    Sridevi, M.
    INTERNATIONAL JOURNAL OF ECOLOGY & DEVELOPMENT, 2022, 37 (01) : 1 - 9
  • [44] ENHANCEMENT OF CHEMOTHERAPY USING ONCOLYTIC VIROTHERAPY: MATHEMATICAL AND OPTIMAL CONTROL ANALYSIS
    Malinzi, Joseph
    Ouifki, Rachid
    Eladdadi, Amina
    Torres, Delfim F. M.
    White, K. A. Jane
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2018, 15 (06) : 1435 - 1463
  • [45] Fighting fire with fire: rewiring tumor cells for oncolytic virotherapy
    Mahoney, Douglas J.
    Stojdl, David F.
    FUTURE ONCOLOGY, 2012, 8 (03) : 219 - 221
  • [46] Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?
    Denton, Nicholas L.
    Chen, Chun-Yu
    Scott, Thomas R.
    Cripe, Timothy P.
    BIOMEDICINES, 2016, 4 (03)
  • [47] Analysis of a mathematical model for tumor therapy with a fusogenic oncolytic virus
    Jacobsen, Karly
    Pilyugin, Sergei S.
    MATHEMATICAL BIOSCIENCES, 2015, 270 : 169 - 182
  • [48] Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters
    Bailey, Kent
    Kirk, Amber
    Naik, Shruthi
    Nace, Rebecca
    Steele, Michael B.
    Suksanpaisan, Lukkana
    Li, Xing
    Federspiel, Mark J.
    Peng, Kah-Whye
    Kirk, David
    Russell, Stephen J.
    PLOS ONE, 2013, 8 (09):
  • [49] Oncolytic virotherapy: Approaches to tumor targeting and enhancing antitumor effects
    Thorne, SH
    Hermiston, T
    Kirn, D
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : 537 - 548
  • [50] Targeting tumor vasculature through oncolytic virotherapy: recent advances
    Bejarano, Marcela Toro
    Merchan, Jaime R.
    ONCOLYTIC VIROTHERAPY, 2015, 4 : 169 - 181